Paradigm Biocapital Advisors LP - Mar 20, 2025 Form SCHEDULE 13G Schedule Report for LENZ Therapeutics, Inc. (LENZ)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
LENZ
Shares outstanding
27.3M shares
Disclosed Ownership
1.42M shares
Ownership
5.2%
Form type
SCHEDULE 13G
Date filed
3/27/2025, 04:21 PM
Date of event
Mar 20, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5.2% 1.42M 1.42M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5.2% 1.42M 1.42M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5.2% 1.42M 1.42M 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.6% 1.25M 1.25M 0 /s/ David K. Kim David K. Kim / Authorized Signatory